Earlier this month the company marked a key milestone when US regulator the FDA accepted its joint new drug application with Tokyo-based Otsuka Pharmaceuticals. the UK NHS , whose "chip-in-a-pill" collaboration with Otsuka was accepted by Proteus Health yesterday , has urged Proteus Health to follow suit and "think about the way they deliver care", adding "it's not sustainable to keep going the way we are". The company's sensor pills enable patients to check the pill is being correctly metabolised, and check they are keeping to their regimen, the latter issue afflicting up to 50% of prescription medication in the US .
the UK NHS , whose "chip-in-a-pill" collaboration with Otsuka was accepted by Proteus Health yesterday , has urged Proteus Health to follow suit and "think about the way they deliver care", adding "it's not sustainable to keep going the way we are". The company's sensor pills enable patients to check the pill is being correctly metabolised, and check they are keeping to their regimen, the latter issue afflicting up to 50% of prescription medication in the US .